Peer review reports
From: Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Original Submission | ||
---|---|---|
13 Oct 2021 | Submitted | Original manuscript |
10 Dec 2021 | Reviewed | Reviewer Report |
24 Jan 2022 | Reviewed | Reviewer Report |
4 Feb 2022 | Author responded | Author comments - Chuansheng Zheng |
9 Feb 2022 | Author responded | Author comments - Chuansheng Zheng |
Resubmission - Version 2 | ||
4 Feb 2022 | Submitted | Manuscript version 2 |
Publishing | ||
21 Feb 2022 | Editorially accepted | |
14 Mar 2022 | Article published | 10.1186/s12885-022-09325-6 |